Astaxanthin Enhances ATP-Binding Cassette Transporter A1/G1 Expressions and Cholesterol Efflux from Macrophages

被引:42
作者
Iizuka, Maki [1 ,3 ]
Ayaori, Makoto [1 ]
Uto-Kondo, Harumi [1 ]
Yakushiji, Emi [1 ]
Takiguchi, Shunichi [1 ]
Nakaya, Kazuhiro [1 ]
Hisada, Tetsuya [2 ]
Sasaki, Makoto [1 ]
Komatsu, Tomohiro [1 ]
Yogo, Makiko [1 ]
Kishimoto, Yoshimi [3 ]
Kondo, Kazuo [3 ]
Ikewaki, Katsunori [1 ]
机构
[1] Natl Def Med Coll, Div Antiaging, Dept Internal Med, Tokorozawa, Saitama 3598513, Japan
[2] Natl Def Med Coll, Dept Publ Hlth & Prevent Med, Tokorozawa, Saitama 3598513, Japan
[3] Ochanomizu Univ, Inst Environm Sci Human Life, Bunkyo Ku, Tokyo 1128610, Japan
关键词
astaxanthin; HDL; cholesterol efflux; ABCA1; ABCG1; HIGH-DENSITY-LIPOPROTEIN; HUMAN ABCG1 GENE; PPAR-ALPHA; IN-VITRO; ABCA1; HDL; PROMOTER; ATHEROSCLEROSIS; INHIBITION; ACTIVATION;
D O I
10.3177/jnsv.58.96
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
ATP-binding cassette transporters (ABC) A1 and G1 are key molecules in cholesterol efflux from macrophages, which is an initial step of reverse cholesterol transport (RCT), a major anti-atherogenic property of high-density lipoprotein (HDL). Astaxanthin is one of the naturally occurring carotenoids responsible for the pink-red pigmentation in a variety of living organisms. Although astaxanthin is known to be a strong antioxidant, it remains unclear through what mechanism of action it affects cholesterol homeostasis in macrophages. We therefore investigated the effects of astaxanthin on cholesterol efflux and ABCA1/G1 expressions in macrophages. Astaxanthin enhanced both apolipoprotein (apo) A-I- and HDL-mediated cholesterol efflux from RAW264.7 cells. In supporting these enhanced cholesterol efflux mechanisms, astaxanthin promoted ABCA1/G1 expression in various macrophages. In contrast, peroxisome proliferator-activated receptor gamma, liver X receptor (LXR) alpha and LxR beta levels remained unchanged by astaxanthin. An experiment using actinomycin D demonstrated that astaxanthin transcriptionally induced ABCA1/G1 expression, and oxysterol depletion caused by overexpression of cholesterol sulfotransferase further revealed that these inductions in ABCA1/G1 were independent of LXR-mediated pathways. Finally, we performed luciferase assays using human ABCA1/G1 promoter-reporter constructs to reveal that astaxanthin activated both promoters irrespective of the presence or absence of LXR-responsive elements, indicating LXR-independence of these activations. In conclusion, astaxanthin increased ABCA1/G1 expression, thereby enhancing apoA-I/HDL-mediated cholesterol efflux from the macrophages in an LXR-independent manner. In addition to the anti-oxidative properties, the potential cardioprotective properties of astaxanthin might therefore be associated with an enhanced anti-atherogenic function of HDL.
引用
收藏
页码:96 / 104
页数:9
相关论文
共 39 条
  • [21] Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and β
    Li, AC
    Binder, CJ
    Gutierrez, A
    Brown, KK
    Plotkin, CR
    Pattison, JW
    Valledor, AF
    Davis, RA
    Willson, TM
    Witztum, JL
    Palinski, W
    Glass, CK
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (11) : 1564 - 1576
  • [22] Expression of the ATP-binding cassette transporter gene ABCG1 (ABC8) in Tangier disease
    Lorkowski, S
    Kratz, M
    Wenner, C
    Schmidt, R
    Weitkamp, B
    Fobker, M
    Reinhardt, J
    Rauterberg, J
    Galinski, EA
    Cullen, P
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (04) : 821 - 830
  • [23] Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice
    Naito, Y
    Uchiyama, K
    Aoi, W
    Hasegawa, G
    Nakamura, N
    Yoshida, N
    Maoka, T
    Takahashi, J
    Yoshikawa, T
    [J]. BIOFACTORS, 2004, 20 (01) : 49 - 59
  • [24] Telmisartan enhances cholesterol eff lux from THP-1 macrophages by activating PPARγ
    Nakaya, Kazuhiro
    Ayaori, Makoto
    Hisada, Tetsuya
    Sawada, Shojiro
    Tanaka, Nobukiyo
    Iwamoto, Noriyuki
    Ogura, Masatsune
    Yakushiji, Emi
    Kusuhara, Masatoshi
    Nakamura, Haruo
    Ohsuzu, Fumitaka
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2007, 14 (03) : 133 - 141
  • [25] Cilostazol enhances macrophage reverse cholesterol transport in vitro and in vivo
    Nakaya, Kazuhiro
    Ayaori, Makoto
    Uto-Kondo, Harumi
    Hisada, Tetsuya
    Ogura, Masatsune
    Yakushiji, Emi
    Takiguchi, Shunichi
    Terao, Yoshio
    Ozasa, Hideki
    Sasaki, Makoto
    Komatsu, Tomohiro
    Ohsuzu, Fumitaka
    Ikewaki, Katsunori
    [J]. ATHEROSCLEROSIS, 2010, 213 (01) : 135 - 141
  • [26] Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: Findings from in vitro and ex vivo studies
    Ozasa, Hideki
    Ayaori, Makoto
    Iizuka, Maki
    Terao, Yoshio
    Uto-Kondo, Harumi
    Yakushiji, Emi
    Takiguchi, Shunichi
    Nakaya, Kazuhiro
    Hisada, Tetsuya
    Uehara, Yoshinari
    Ogura, Masatsune
    Sasaki, Makoto
    Komatsu, Tomohiro
    Horii, Shunpei
    Mochizuki, Seibu
    Yoshimura, Michihiro
    Ikewaki, Katsunori
    [J]. ATHEROSCLEROSIS, 2011, 219 (01) : 141 - 150
  • [27] α-tocopherol disturbs macrophage LXRα regulation of ABCA1/G1 and cholesterol handling
    Rode, Sabine
    Rubic, Tina
    Lorenz, Reinhard L.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 369 (03) : 868 - 872
  • [28] The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver
    Sabol, SL
    Brewer, HB
    Santamarina-Fojo, S
    [J]. JOURNAL OF LIPID RESEARCH, 2005, 46 (10) : 2151 - 2167
  • [29] Structural determinants of allosteric ligand activation in RXR heterodimers
    Shulman, AI
    Larson, C
    Mangelsdorf, DJ
    Ranganathan, R
    [J]. CELL, 2004, 116 (03) : 417 - 429
  • [30] Effect of Sulfonylurea Agents on Reverse Cholesterol Transport in Vitro and Vivo
    Terao, Yoshio
    Ayaori, Makoto
    Ogura, Masatsune
    Yakushiji, Emi
    Uto-Kondo, Harumi
    Hisada, Tetsuya
    Ozasa, Hideki
    Takiguchi, Shunichi
    Nakaya, Kazuhiro
    Sasaki, Makoto
    Komatsu, Tomohiro
    Iizuka, Maki
    Horii, Shunpei
    Mochizuki, Seibu
    Yoshimura, Michihiro
    Ikewaki, Katsunori
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2011, 18 (06) : 513 - 530